Immune modulating drugs and oral anticoagulation in kidney transplant recipients: comparison of direct oral anticoagulants versus antagonist of vitamin-k. results from a multicenter prospective study

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: direct oral anticoagulants (DOACs) are a well-known alternative to conventional antagonist of vitamin-K (avK) and have emerged as the preferred choice due to their safety and efficacy profile. However, immune modulating drugs as cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, F, Casanova, A, Simone, S, Pellegrino, P L, D'arienzo, G, Brunetti, N D, Pesce, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.5.1 - Oral Anticoagulation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207264/
http://dx.doi.org/10.1093/europace/euad122.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207264/
http://dx.doi.org/10.1093/europace/euad122.211

Ejemplares similares